CG Oncology, Inc. has grown revenue 345% a year over three years and 345% a year over five. Revenue growth, 3-year annual rate: +345% (Biotechnology median +17%). Revenue growth, 5-year rate: +345%, growth has slowed since the five-year average. Years of annual history on file: 3, FY2023 to FY2025, as filed.

CGONCG Oncology, Inc.

Healthcare

$63.86+73% 1Y

$63.86

$36.4852 weeks$80.66

Is it growing?

Good

Growing: revenue growing +1030% year on year and operating margin widening (+525076.9 points).

2 good, 1 without data

Revenue trend+1030% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+525076.9 points operating

Trailing-twelve-month operating margin, -4691.0% now against -529767.9% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CGON growing?

CG Oncology, Inc. has grown revenue 345% a year over three years and 345% a year over five.

+345%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +345%
Revenue growth, 5-year rate · +345% over three · growth has slowed since the five-year average
Years of annual history on file: 3
Years of annual history on file · FY2023 to FY2025, as filed

Details›